ATE245448T1 - Zellwachstumshemmende zusammensetzungen die kalzium-zufluss-blocker enthalten - Google Patents

Zellwachstumshemmende zusammensetzungen die kalzium-zufluss-blocker enthalten

Info

Publication number
ATE245448T1
ATE245448T1 AT97900169T AT97900169T ATE245448T1 AT E245448 T1 ATE245448 T1 AT E245448T1 AT 97900169 T AT97900169 T AT 97900169T AT 97900169 T AT97900169 T AT 97900169T AT E245448 T1 ATE245448 T1 AT E245448T1
Authority
AT
Austria
Prior art keywords
compositions
cell death
influx
influx blocker
agent
Prior art date
Application number
AT97900169T
Other languages
English (en)
Inventor
Stuart Alan Berger
Jennifer Lynn Gommerman
Original Assignee
Wellesley Hospital Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellesley Hospital Found filed Critical Wellesley Hospital Found
Application granted granted Critical
Publication of ATE245448T1 publication Critical patent/ATE245448T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT97900169T 1996-01-11 1997-01-13 Zellwachstumshemmende zusammensetzungen die kalzium-zufluss-blocker enthalten ATE245448T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58400096A 1996-01-11 1996-01-11
PCT/CA1997/000019 WO1997025063A1 (en) 1996-01-11 1997-01-13 Compositions including calcium influx blockers for inhibiting cell growth

Publications (1)

Publication Number Publication Date
ATE245448T1 true ATE245448T1 (de) 2003-08-15

Family

ID=24335483

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97900169T ATE245448T1 (de) 1996-01-11 1997-01-13 Zellwachstumshemmende zusammensetzungen die kalzium-zufluss-blocker enthalten

Country Status (13)

Country Link
EP (1) EP0873137B1 (de)
JP (1) JP2000513708A (de)
KR (1) KR19990077183A (de)
CN (1) CN1099296C (de)
AT (1) ATE245448T1 (de)
AU (1) AU732012B2 (de)
BR (1) BR9710942A (de)
CA (1) CA2242866A1 (de)
DE (1) DE69723670D1 (de)
IL (1) IL125297A0 (de)
PL (1) PL327921A1 (de)
TR (1) TR199801359T2 (de)
WO (1) WO1997025063A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000054332A (ko) * 2000-06-01 2000-09-05 김진경 혈관내피세포 성장인자 억제제에 의한 암 치료법
AU2003251650A1 (en) * 2002-07-29 2004-02-23 Novartis Ag Screening for agents suitable for treatment of leukocyte associated inflammatory diseases
KR100573881B1 (ko) * 2003-11-29 2006-04-26 장양수 허혈증상 치료제
CN104324039A (zh) * 2014-10-20 2015-02-04 付茜 一种治疗人身体表面脂肪瘤的药剂及使用方法
CN110106146B (zh) * 2019-03-28 2021-04-02 中国人民解放军军事科学院军事医学研究院 化合物富马酸酮替芬在促进干细胞因子合成和分泌中的用途
CN113384551B (zh) * 2021-05-07 2022-03-08 西安交通大学 一种减少肿瘤内过量钙离子的仿生纳米载体的制备方法和应用

Also Published As

Publication number Publication date
AU1362897A (en) 1997-08-01
WO1997025063A1 (en) 1997-07-17
TR199801359T2 (xx) 1998-10-21
DE69723670D1 (de) 2003-08-28
JP2000513708A (ja) 2000-10-17
CN1099296C (zh) 2003-01-22
PL327921A1 (en) 1999-01-04
EP0873137B1 (de) 2003-07-23
CA2242866A1 (en) 1997-07-17
EP0873137A1 (de) 1998-10-28
IL125297A0 (en) 1999-03-12
CN1213315A (zh) 1999-04-07
KR19990077183A (ko) 1999-10-25
AU732012B2 (en) 2001-04-12
BR9710942A (pt) 2000-10-24

Similar Documents

Publication Publication Date Title
LV10180A (lv) Farmaceitiska kompozicija
KR960701051A (ko) 이미다조피리딘 및 이를 위장 질환의 치료에 사용하는 방법(imidazopyridines and their use in treating castrointestinal diseases)
ATE355374T1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
CA2023810A1 (fr) Compositions pharmaceutiques de type "pates a l'eau"
PE30891A1 (es) Composiciones y metodos terapeuticos sinergicos
AR024516A1 (es) Compuestos bi-aromaticos analogos de la vitamina d, su utilizacion, composicion farmaceutica y composicion cosmetica que comprenden al menos uno de dichos compuestos y utilizacion de dicha composicion cosmetica.
ATE227717T1 (de) 3-pyridylenantiomere und ihre verwendung als analgetika
BRPI0408236A (pt) método para radiofluoração, composto, composição radiofarmacêutica, uso de um composto, e, métodos para gerar uma imagem de um corpo humano ou animal e para monitorar o efeito de tratamento de um corpo humano ou animal com um medicamento para combater uma condição associada com cáncer
ATE364699T1 (de) Humanisierte antikörper gegen humanes gp39, zusammensetzungen die diese enthalten und deren therapeutische verwendungen
ATE214943T1 (de) Therapeutische zusammensetzungen die monoklonale antikörper enthalten gegen den menschlichen rezeptor für epidermalen wachstumsfaktor
DE60040753D1 (de) Therapeutische verwendungen von steroiden bei blutzellmangelzustaenden
DE69430440D1 (de) Zusammensetzungen zur inhibition von retroviraler verbreitung, die 2',3'-dideoxy-inosin und hydroxyharnstoff enthalten
DE69332713D1 (de) Verwendung von Histamine-2 Agonisten zur Behandlung sexueller Funktionsstörungen
ATE135208T1 (de) Verwendung von nervonsäure und langkettiger fettsäuren zur behandlung demyelinisierender erkrankungen
DE60033649D1 (de) Verbindungen und therapeutische methoden
ATE62414T1 (de) Mittel zur behandlung von herzerkrankungen.
ES2106531T3 (es) Compuestos de dibenzoxazepina substituidos en 2, 3, 4, 5, 6, 7, 8, 9 y/o 10, composiciones farmaceuticas y metodos de uso.
ES2135769T3 (es) Derivados de isotiourea como inhibidores de no-sintasa.
ATE240725T1 (de) Mittel zur behandlung lichtgeschädigter haut die einen rar-alpha antagonisten und ein multiselektives retinoid enthalten
DE69825279D1 (de) Verwendung von glukosamin und glukosaminderivaten zur schnellen linderung von juckreiz oder lokalisiertem schmerz
DE69723670D1 (de) Zellwachstumshemmende zusammensetzungen die kalzium-zufluss-blocker enthalten
BRPI0409699A (pt) métodos de indução do efeito diurético, de indução, manutenção ou restauração do efeito diurético de diurético não modificador de adenosina, de manutenção, restauração ou melhoria da função renal em paciente, de indução de diurese, de prevenção do inìcio de deficiência renal em paciente com sobrecarga de fluidos ou chf, de tratamento de paciente que sofre de chf e de melhoria dos resultados globais da saúde, composição farmacêutica e seus usos
MX9403032A (es) Quinolil-dihidropiridinas condensadas, procedimiento para su fabricacion ysu uso en medicamentos.
MX9300205A (es) Compuestos policiclicos disubstituidos y composicion farmaceutica que los contiene.
MX9300203A (es) Compuestos policiclicos disubstituidos y composicion farmaceutica que los contiene.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties